Linklaters advises Siemens Healthineers on the acquisition of Advanced Accelerator Applications Molecular Imaging from Novartis
Linklaters advises Siemens Healthineers on the acquisition of Advanced Accelerator Applications Molecular Imaging from Novartis. The acquired company will be known as Advanced Accelerator Applications, a Siemens Healthineers company.
Advanced Accelerator Applications Molecular Imaging is a European manufacturing and distribution network of diagnostic radiopharmaceuticals for positron emission tomography (PET) scans. The transaction includes the manufacturing and distribution network, its workforce, its product portfolio and relationships with radioligand imaging developers. The transaction was closed in December 2024.
The acquisition complements the Siemens Healthineers PETNET Solutions network of 47 radiopharmacies, primarily in the U.S., with an additional 13 manufacturing sites across France, Spain, Portugal, Italy and Germany, as well as product distribution into Switzerland. Proximity to patients is essential for radiopharmaceuticals, which have short half-lives and must be used on the day of manufacture.
The Linklaters team was led by Dr Timo Engelhardt (Partner) and Dr Ruprecht von Maltzahn (Counsel; both Corporate/M&A, Munich). Further team members include Andreas Schaflitzl (Partner, Tax, Munich), Dr Julia Schönbohm (Partner, IP/LAI, Frankfurt), Matthew Devey (Partner, Employment, Frankfurt), Anne Wachsmann (Partner, Antitrust & Foreign Investment, Paris), Lionel Vuidard (Partner, Employment, Paris), Matthieu Blayney (Counsel, Antitrust & Foreign Investment, Paris), Pierre Sikorav (Counsel, Energy & Infrastructure, Paris), Alice Klein (Counsel, Employment, Paris), Juan Passas (Consultant, Antitrust & Foreign Investment, Madrid), Daniel Gloor (Managing Associate, Corporate/M&A, Munich), Dr Alexander Zitzl (Managing Associate, Tax, Munich), Lisa Jäger (Managing Associate, IP/LAI, Frankfurt), Michal Szperzynski (Managing Associate, Corporate/M&A, Warsaw), Maximilian Huchel (Associate, Corporate/M&A, Munich), Laetitia Aria (Associate, Corporate/M&A, Munich), Barbara Rivera (Associate, Antitrust & Foreign Investment, Madrid), Zoé Giovanetti (Associate, Corporate/M&A, London), Mario Saenz (Junior Associate, Antitrust & Foreign Investment, Madrid), Estel Robert (Associate, Corporate/M&A, Paris), Maximilian Kühn (Associate, Real Estate, Munich), José Moreno (Associate, Corporate/M&A, Lisbon), Cecilia Drepper (Associate, IP/LAI, Frankfurt), Dr Alexander Al Hamwi (Associate, Tax, Munich), Cristiana Vieira Bento (Associate, Antitrust & Foreign Investment, Lisbon), Gwendoline Vannarath (Associate, Energy & Infrastructure, Paris), Lucia Herrero (Associate, Corporate/M&A, Madrid), Carlos Gil (Associate, Real Estate, Madrid), Martina Fariseo (Associate, Corporate/M&A, Milan), Augusto Fracasso (Associate, Corporate/M&A, Milan), Inês Gamito (Associate, Antitrust & Foreign Investment, Lisbon), Cécile Boulé (Associate, Employment, Paris), and Iuliia Matveieva (Transaction Lawyer, Corporate/M&A, Munich).
